Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other financing activities (2016 - 2017)

Lisata Therapeutics (LSTA) has disclosed Other financing activities for 4 consecutive years, with $231.0 as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Other financing activities fell 99.53% year-over-year to $231.0, compared with a TTM value of $231.0 through Sep 2018, up 100.93%, and an annual FY2017 reading of -$74000.0, down 101.85% over the prior year.
  • Other financing activities was $231.0 for Q4 2017 at Lisata Therapeutics, down from $42314.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $49446.0 in Q4 2016 and bottomed at -$138127.0 in Q3 2016.